IDEXX Laboratories
IDXX
Delayed Nasdaq - 08/16 10:00:01 pm
243.26USD
+0.7%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 20172018
Sales1 9692 223
EBITDA496577
Operating profit (EBIT)413492
Pre-Tax Profit (EBT)--
Net income263370
EPS ( $ )2,944,18
Dividend per Share ( $ )--
Yield--
Announcement Date02/01/2018
11:44am
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 20172018
Debt789808
Finance--
Operating income (EBITDA)496577
Leverage
(Debt/EBITDA)
1,59x1,40x
Capital Expenditure74,4118
Book Value Per Share (BVPS)-0,62 $-0,20 $
Cash Flow per Share4,17 $5,94 $
Announcement Date02/01/2018
11:44am
-
Balance Sheet Analysis
Financial Ratios
Size 2018e 2019e
Capitalization 20 918 M$ -
Entreprise Value (EV) 21 726 M$ 21 511 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 58,2x 50,0x
Capitalization / Revenue 9,41x 8,56x
EV / Revenue 9,77x 8,80x
EV / EBITDA 37,7x 32,7x
Yield (DPS / Price) - -
Price to book (Price / BVPS) -1 195x 447x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 22,1% 23,2%
operating Leverage (Delta EBIT / Delta Sales) 1,49x 1,54x
Net Margin (Net Profit / Revenue) 16,6% 17,4%
ROA (Net Profit / Asset) 33,4% 34,9%
ROE (Net Profit / Equities) 863% -
Rate of Dividend - -
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   5,30% 4,75%
Cash Flow / Sales 23,1% 23,9%
Capital Intensity (Assets / Sales) 0,50x 0,50x
Financial Leverage (Net Debt / EBITDA) 1,40x 0,90x
Price Earning Ratio
BNA & Dividende